Results 121 to 130 of about 96,537 (297)
Abstract Background Real‐world data on Peyronie's disease remains limited. Objectives Describe the demographics, clinical characteristics, and therapeutic management of Peyronie's disease patients in the United States. Materials and methods A retrospective analysis was conducted using the PearlDiver Mariner database (2010–2022).
Angelo Orsini+15 more
wiley +1 more source
Action of Venom Phosphodiesterase on Deoxyribonucleic Acid
Edward J. Williams+2 more
openalex +1 more source
Abstract Background Erectile dysfunction in people living with HIV is a multifactorial disease, but the role of penile vascular status assessed by dynamic penile color Doppler echography is underexplored. Objectives This study assessed penile vascular status in young males living with HIV experiencing erectile dysfunction, comparing them to HIV ...
Giorgio Tiecco+9 more
wiley +1 more source
Bull semen phosphodiesterase [PDF]
A Kher, S R Anand
openaire +3 more sources
Abstract Objectives To evaluate the risk of priapism in patients undergoing Dynamic—Penile duplex ultrasound (D‐PDU) who were referred to our Unit between January 2022 and December 2023. Patients and methods We enrolled 292 patients, of whom 268 underwent Dynamic—Penile duplex ultrasound for erectile dysfunction and 24 for Peyronie's disease.
Giuseppe Grande+6 more
wiley +1 more source
Activity of 3′, 5′-AMP phosphodiesterase in liver and adipose tissue of normal and diabetic rats
B. Müller‐Oerlinghausen+3 more
openalex +1 more source
Abstract Background Low‐intensity shockwave therapy (LiST) is a first‐line treatment for vasculogenic erectile dysfunction (ED). However, its efficacy in challenging cases, such as ED solely due to type 2 diabetes mellitus (DM) or coronary artery disease (CAD), has not been adequately assessed.
Nikolaos Pyrgidis+3 more
wiley +1 more source
An effect of insulin on adipose-tissue adenosine 3′:5′-cyclic monophosphate phosphodiesterase [PDF]
Ernest G. Loten, J. G. T. Sneyd
openalex +1 more source